Insmed
INSM
#764
Rank
A$43.65 B
Marketcap
A$202.52
Share price
-0.85%
Change (1 day)
67.33%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -A$1.71 Billion

According to Insmed's latest financial reports the company's current earnings are A$0.44 Billion. In 2024 the company made an earning of -A$1.18 Billion a decrease over its 2023 earnings that were of -A$0.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$1.71 Billion45.13%
2024 -A$1.18 Billion23.71%
2023 -A$0.96 Billion45.77%
2022 -A$0.66 Billion15.83%
2021 -A$0.57 Billion50.19%
2020 -A$0.38 Billion16.4%
2019 -A$0.33 Billion-23.9%
2018 -A$0.43 Billion59.35%
2017 -A$0.27 Billion8.52%
2016 -A$0.25 Billion47.25%
2015 -A$0.17 Billion34.53%
2014 -A$0.13 Billion58.83%
2013 -A$77.89 Million35.14%
2012 -A$57.64 Million-31.92%
2011 -A$84.67 Million854.92%
2010 -A$8.87 Million-105.22%
2009 A$0.16 B-905.06%
2008 -A$21.09 Million-27.31%
2007 -A$29.01 Million-62.41%
2006 -A$77.17 Million98.19%
2005 -A$38.94 Million0.03%
2004 -A$38.93 Million159.07%
2003 -A$15.03 Million-69.31%
2002 -A$48.95 Million
2000 -A$44.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.20 B-1,585.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A$14.03 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.33 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-A$0.36 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$32.99 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$6.25 M-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA